Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases
Journal of Medicinal Chemistry · 26.03.2026 · 69 (6) · 6790-6815
DOI: 10.1021/acs.jmedchem.5c03050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 16.03.2026. Verfasst von Enrique Madruga und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Biológicas "Margarita Salas"─CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Immediate-Early Proteins, Protein Kinase Inhibitors, Neurodegenerative Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Generalitat Valenciana, Ministerio de Universidades, Ministerio de Ciencia, Innovaci?n y Universidades.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro de Investigaciones Biológicas "Margarita Salas"─CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
- Centro de Investigación Biomédica en Red en Enfermedades Neurodegeneartivas (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universitas Miguel Hernández, 03202 Elche, Alicante, Spain.
- Instituto de Investigaciones Biomédica "Sols-Morreale"─CSIC/UAM, Arturo Duperier 4, 28039 Madrid, Spain.
- Instituto de Investigación Sanitaria La Paz (IdiPaz), Paseo de la Castellana, 261, 28046 Madrid, Spain.
ORCID-Profile: Enrique Madruga, Carmen Gil, Ana Martinez
Förderung
- Generalitat Valenciana
- Ministerio de Universidades
- Ministerio de Ciencia, Innovaci?n y Universidades
- Centro de Investigaci?n Biom?dica en Red sobre Enfermedades Neurodegenerativas
- International Center for Aging Research
Zitieren
APA
Madruga, E., Garcia-Rubia, A., Sanchez-Nuñez, C., Martinez-Gonzalez, L., Fernandez-Escamilla, A. M., Lastres-Becker, I., Gil, C., & Martinez, A. (2026). Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases. Journal of Medicinal Chemistry, 69(6), 6790-6815. https://doi.org/10.1021/acs.jmedchem.5c03050
Vancouver
Madruga E, Garcia-Rubia A, Sanchez-Nuñez C, Martinez-Gonzalez L, Fernandez-Escamilla AM, Lastres-Becker I, et al. Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases. Journal of Medicinal Chemistry. 2026;69(6):6790-6815. doi:10.1021/acs.jmedchem.5c03050
BibTeX
@article{Madruga2026,
author = {Madruga, Enrique and Garcia-Rubia, Alfonso and Sanchez-Nuñez, Carlos and Martinez-Gonzalez, Loreto and Fernandez-Escamilla, Ana María and Lastres-Becker, Isabel and Gil, Carmen and Martinez, Ana},
title = {Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {6},
pages = {6790--6815},
doi = {10.1021/acs.jmedchem.5c03050}
}
EUVIMED